Document Detail

Expression profile of apoptotic mediators and proliferative markers in oral squamous cell carcinoma.
MedLine Citation:
PMID:  21057559     Owner:  NLM     Status:  In-Process    
BACKGROUND: Oral squamous cell carcinoma (OSCC) represents a major health problem worldwide. It is therefore essential to develop a deeper understanding of its biology. Beside the recent hypothesis of cancer stem cells, the consideration of its cell death and cell proliferation has emerged as important diagnostic and prognostic tools. PURPOSE OD THE STUDY: Detection of the proportion of cell loss monitored by apoptosis-related genes, p53, p21 and Bcl2, and their relationship to the pathological proliferation parameter, PCNA in OSCC. Furthermore, discussion of the hypothesis of cancer stem cell biology in OSCC would be anticipated.
MATERIAL AND METHODS: Archival 35 tissue embedded paraffin blocks, that were previously diagnosed as well to moderately differentiated OSCC, were immunohistochemically stained using a panel of antibodies including apoptotic mediators, p53, p21, Bcl2, and proliferation marker, PCNA. Immunoexpression was scored using a semiquantitative scale and statistically analyzed.
RESULTS: The clinico-pathological data revealed that mean age was 46.9±8.2 and the tongue was the most affected site, followed by the palate then the floor of the mouth. There was no significant difference between metastasizing and non-metastasizing patients regarding age or gender (p=0.174, 0.404, respectively). On the other hand, variable profile patterns of the investigated indicators existed, where PCNA positively immunostaining cells was 100%while P21 recorded the higher percentage of negatively immunoreactive cells (42.9%). A common trait for the studied cell cycle indicators was that the basal and suprabasal epithelial cells as well as the peripheral cells of the invading nests were the harbor of immunoreactivity. Meanwhile, PCNA immunopositivity was revealed in all epithelial layers plus stromal cells.
CONCLUSIONS: Assessment of the studied cell cycle regulators may be valuable to judge tumorigenesis of OSCC. Furthermore, deregulation of cell cycle control might aid in the attainment of genetic changes in normal stem cells to be altered to cancer stem cells.
Mohamed M Ahmed
Related Documents :
9488309 - Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration...
8552379 - Adenovirus-mediated p16/cdkn2 gene transfer induces growth arrest and modifies the tran...
14731719 - In search of the functions of normal p53 protein.
10675489 - Comparison of two human ovarian carcinoma cell lines (a2780/cp70 and mcas) that are equ...
18608579 - P53 status-dependent sensitization of human tumour cells to hyperthermia by plant flavo...
15681459 - Inhibition of cell division by the human cytomegalovirus ie86 protein: role of the p53 ...
10757309 - Cell death and cell-cycle arrest induced by incorporation of [3h]thymidine into human h...
22496249 - Detection of cells captured with antigens on shear horizontal surface-acoustic-wave sen...
23524189 - Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the Egyptian National Cancer Institute     Volume:  21     ISSN:  1110-0362     ISO Abbreviation:  J Egypt Natl Canc Inst     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2010-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9424566     Medline TA:  J Egypt Natl Canc Inst     Country:  Egypt    
Other Details:
Languages:  eng     Pagination:  85-92     Citation Subset:  IM    
The Deparment of Oral Pathology, Al-Azhar University, Cairo, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exploration of the histogenesis of congenital granular cell epulis: an immunohistochemical study.
Next Document:  Frequency of expression of RHAMM/CD168 in Egyptian patients with CML.